Gender bias in drug dosage trials and overmedicated women
A new study from the journal Biology of Sex Differences found an association between sex biases in drug dosage trials and the overmedication of women.
According to investigators, women are more likely than men to experience adverse drug reactions from medications, as clinical trials have historically focused on men.
In the August issue of Contemporary OB/GYN, Editor-in-Chief Dr. Catherine Y. Spong discussed the ways in which women’s health research has and continues to be marginalized. Read her full editorial here.
“Only in 1993, with the passage of the National Institutes of Health Revitalization Act, were women mandated to be included in NIH-funded research,” wrote Dr. Spong.
For additional details on the study’s findings, visit our sister publication, Drug Topics.
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More
